Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
British Journal of Haematology|April 1, 1991
Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cellsM Nobuyoshi, M Kawano, H Tanaka, et al.Blood|February 1, 1990
Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1 beta osteoclast activating factor-induced bone resorptionH Ishikawa, H Tanaka, K Iwato, et al.Leukemia|September 14, 1999
Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignanciesK Tanaka, M Arif, M Eguchi, et al.Cancer Genetics and Cytogenetics|November 24, 1999
Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration ratesK Tanaka, M Arif, M Eguchi, et al.Nature|March 3, 1988
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasM Kawano, T Hirano, T Matsuda, et al.British Journal of Haematology|August 1, 1995
A specific chromosome abnormality of t(4;12)(q11-12;p13) in CD7+ acute leukaemiaH Harada, H Asou, T Kyo, et al.Blood|May 1, 1989
Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myelomaM Kawano, I Yamamoto, K Iwato, et al.American Journal of Hematology|August 1, 1989
BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cellsO Tanabe, M Kawano, H Tanaka, et al.British Journal of Haematology|January 1, 1993
Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cellsH Ishikawa, M M Kawano, K Okada, et al.Cancer Genetics and Cytogenetics|February 13, 2001
Restricted chromosome breakpoint sites on 11q22-q23.1 and 11q25 in various hematological malignancies without MLL/ALL-1 gene rearrangementK Tanaka, M Eguchi, M Eguchi-Ishimae, et al.Pageof 4